128 related articles for article (PubMed ID: 11415849)
1. Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome.
Rasgon N; Serra M; Biggio G; Pisu MG; Fairbanks L; Tanavoli S; Rapkin A
Eur J Endocrinol; 2001 Jul; 145(1):25-33. PubMed ID: 11415849
[TBL] [Abstract][Full Text] [Related]
2. Allopregnanolone concentrations and premenstrual syndrome.
Monteleone P; Luisi S; Tonetti A; Bernardi F; Genazzani AD; Luisi M; Petraglia F; Genazzani AR
Eur J Endocrinol; 2000 Mar; 142(3):269-73. PubMed ID: 10700721
[TBL] [Abstract][Full Text] [Related]
3. Allopregnanolone in women with premenstrual syndrome.
Bicíková M; Dibbelt L; Hill M; Hampl R; Stárka L
Horm Metab Res; 1998 Apr; 30(4):227-30. PubMed ID: 9623639
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine response to an intravenous L-tryptophan challenge in women with premenstrual syndrome.
Rasgon N; McGuire M; Tanavoli S; Fairbanks L; Rapkin A
Fertil Steril; 2000 Jan; 73(1):144-9. PubMed ID: 10632430
[TBL] [Abstract][Full Text] [Related]
5. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
[TBL] [Abstract][Full Text] [Related]
6. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome].
Gao H; Xia T; Qiao MQ
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974
[TBL] [Abstract][Full Text] [Related]
7. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one.
Wang M; Seippel L; Purdy RH; Bãckström T
J Clin Endocrinol Metab; 1996 Mar; 81(3):1076-82. PubMed ID: 8772579
[TBL] [Abstract][Full Text] [Related]
8. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
[TBL] [Abstract][Full Text] [Related]
9. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.
Lombardi I; Luisi S; Quirici B; Monteleone P; Bernardi F; Liut M; Casarosa E; Palumbo M; Petraglia F; Genazzani AR
Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499
[TBL] [Abstract][Full Text] [Related]
10. Brain-derived neurotrophic factor plasma variation during the different phases of the menstrual cycle in women with premenstrual syndrome.
Cubeddu A; Bucci F; Giannini A; Russo M; Daino D; Russo N; Merlini S; Pluchino N; Valentino V; Casarosa E; Luisi S; Genazzani AR
Psychoneuroendocrinology; 2011 May; 36(4):523-30. PubMed ID: 20933336
[TBL] [Abstract][Full Text] [Related]
11. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid levels of monoamine metabolites. A preliminary study of their relation to menstrual cycle phase, sex steroids, and pituitary hormones in healthy women and in women with premenstrual syndrome.
Eriksson E; Alling C; Andersch B; Andersson K; Berggren U
Neuropsychopharmacology; 1994 Nov; 11(3):201-13. PubMed ID: 7532413
[TBL] [Abstract][Full Text] [Related]
13. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms.
Redei E; Freeman EW
Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654
[TBL] [Abstract][Full Text] [Related]
14. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
[TBL] [Abstract][Full Text] [Related]
15. Increased neuroactive steroid concentrations in women with bipolar disorder or major depressive disorder.
Hardoy MC; Serra M; Carta MG; Contu P; Pisu MG; Biggio G
J Clin Psychopharmacol; 2006 Aug; 26(4):379-84. PubMed ID: 16855455
[TBL] [Abstract][Full Text] [Related]
16. The correlation between neurosteroids and neurotransmitters with liver yang rising and liver qi stagnation types of premenstrual syndrome.
Gao H; Shang YZ; Xia T; Qiao MQ; Zhang HY; Ma YX
Gynecol Endocrinol; 2014; 30(12):913-7. PubMed ID: 25211539
[TBL] [Abstract][Full Text] [Related]
17. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
[TBL] [Abstract][Full Text] [Related]
18. Serum leptin levels in patients with premenstrual syndrome treated with GnRH analogues alone and in association with tibolone.
Tommaselli GA; Di Carlo C; Bifulco G; Di Spiezio Sardo A; Pellicano M; Nappi C
Clin Endocrinol (Oxf); 2003 Dec; 59(6):716-22. PubMed ID: 14974912
[TBL] [Abstract][Full Text] [Related]
19. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle.
Innala E; Bäckström T; Poromaa IS; Andersson C; Bixo M
Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1445-52. PubMed ID: 22924787
[TBL] [Abstract][Full Text] [Related]
20. Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone.
Seippel L; Eriksson O; Grankvist K; von Shoultz B; Bäckström T
Gynecol Endocrinol; 2000 Jun; 14(3):173-81. PubMed ID: 10923278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
